π¬ New Blood Marker Slows ALS in Mice Study
Researchers have identified a human blood marker that appears to slow the progression of Amyotrophic Lateral Sclerosis (ALS) in mice. The study was conducted by a team at a specific unnamed research institute. These findings were published on October 15, 2023, detailing the compound's effect. This research offers a promising avenue for developing new treatments for this devastating neurological condition. Further clinical trials are planned to test the compound's safety and efficacy in human subjects.